EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Improving incretin-mediated body weight loss via energy expenditure

Andrew J Elmendorf, Jonathan D Douros, Patrick J Knerr, Jonathan N Flak

Trends in Endocrinology & Metabolism · 2026-08 · 37 (8) · 764-774

DOI: 10.1016/j.tem.2025.12.004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Endocrinology & Metabolism, 2026-08. Verfasst von Andrew J Elmendorf und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN, USA. Hauptthemen laut MEDLINE: Energy Metabolism, Weight Loss, Incretins, Obesity. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Incretin-based therapies have transformed obesity and type 2 diabetes treatment. While current therapeutics safely reduce food intake and lower body weight, a compensatory drop-in basal metabolic rate represents a barrier to sustainable weight loss. Current efforts aim to incorporate energy expenditure (EE) stimulation with the anorectic actions currently available in the clinic. Glucagon receptor agonism, for instance, has demonstrated the benefit of a multipronged increase in EE; however, compensatory challenges persist. We detail peripheral mechanisms that can increase EE independent of activity and the key central mechanisms controlling them. Understanding the complex interplay between these mechanisms and their central modulation is critical for a coordinated engagement of EE pathways to complement and improve current weight loss treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Energy MetabolismWeight LossIncretinsObesityHumansAnimalsDiabetes Mellitus, Type 2

Stichwörter der Autor:innen

central nervous systemenergy expenditureglucagonincretinsobesitytype 2 diabetes

Substanzen

Incretins

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Indiana Biosciences Research Institute, Indianapolis, IN, USA.
  • Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN, USA. Electronic address: jflak@iu.edu.

Förderung

  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Elmendorf, A. J., Douros, J. D., Knerr, P. J., & Flak, J. N. (2026). Improving incretin-mediated body weight loss via energy expenditure. Trends in Endocrinology & Metabolism, 37(8), 764-774. https://doi.org/10.1016/j.tem.2025.12.004

Vancouver

Elmendorf AJ, Douros JD, Knerr PJ, Flak JN. Improving incretin-mediated body weight loss via energy expenditure. Trends in Endocrinology & Metabolism. 2026;37(8):764-774. doi:10.1016/j.tem.2025.12.004

BibTeX
@article{Elmendorf2026,
  author = {Elmendorf, Andrew J and Douros, Jonathan D and Knerr, Patrick J and Flak, Jonathan N},
  title = {Improving incretin-mediated body weight loss via energy expenditure},
  journal = {Trends in Endocrinology & Metabolism},
  year = {2026},
  volume = {37},
  number = {8},
  pages = {764--774},
  doi = {10.1016/j.tem.2025.12.004}
}
Kostenlos starten →